NANO-X IMAGING LTD (NASDAQ: NNOX) and USARAD announced an advanced radiology diagnostics service combining over 300 expert radiologists and artificial intelligence (AI) decision support algorithms and solutions.
Nanox and USARAD plan to use AI algorithms (including 2D, and 3D tomosynthesis) to provide analysis of large datasets combined with expert radiologists’ interpretations through a unique proprietary workflow that prioritizes urgent cases. The service is planned to be launched with over 20 FDA 510(k)-cleared AI solutions after strategically partnering with several leading companies, including Nanox AI and QUREAI (https://www.qure.ai).
The program is available in three categories:
For more information, please submit the form below and someone will contact you within 24 hours: